Clincosm LogoSign in Get a demo

Ocular Inflammation

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ocular Inflammation, Ocular Prostheses Trial in Rennes (Hydrocortisone, Dexamethasone, Povidone)

Not yet recruiting
  • Ocular Inflammation
  • Ocular Prostheses
  • Rennes, France
    Centre Hospitalier Universitaire de Rennes _ Pontchaillou
Dec 20, 2022

Dry Eye, Keratoconjunctivitis Sicca, Ocular Inflammation Trial in Mexico City (punctum plug insertion, Eye Drops, Lubricant)

Recruiting
  • Dry Eye
  • +2 more
  • punctum plug insertion
  • Eye Drops, Lubricant
  • Mexico City, Coyoacán, Mexico
    Asociación para Evitar la Ceguera en México (APEC)
Nov 9, 2022

Biomarkers in Ocular Inflammation and Uveitis

Enrolling by invitation
  • Uveitis
  • Ocular Inflammation
    • Bethesda, Maryland
      National Eye Institute (NEI)
    Aug 24, 2022

    Cataract, Ocular Inflammation, Ocular Hypertension Trial (Intraoperative delivery of medication, Kenalog (Triamcinolone),

    Not yet recruiting
    • Cataract
    • +3 more
    • Intraoperative delivery of medication, Kenalog (Triamcinolone)
    • Topical post-operative eyedrops, Prednisolone acetate
    • (no location specified)
    Aug 4, 2022

    Ocular Inflammation, Cataract Trial in Campinas (SATURNO II association, Vigadexa®)

    Completed
    • Ocular Inflammation
    • Cataract
    • Campinas, São Paulo, Brazil
      Allegisa
    Mar 4, 2022

    Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain Trial in Cleveland (Dexamethasone Ophthalmic Insert,

    Enrolling by invitation
    • Vitreoretinal Surgery
    • +3 more
    • Dexamethasone Ophthalmic Insert
    • Prednisolone Acetate 1% Oph Susp
    • Cleveland, Ohio
      Cole Eye Institute, Cleveland Clinic
    Feb 24, 2022

    Ocular Surface Disease, Ocular Inflammation Trial in Rome (CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion, cationorm eye

    Active, not recruiting
    • Ocular Surface Disease
    • Ocular Inflammation
    • CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion
    • cationorm eye drops
    • Rome, Italy
      University Campus Bio Medico
    Jan 5, 2022

    Ocular Inflammation Trial (ISV-303, DuraSite Vehicle)

    Completed
    Has Results
    • Ocular Inflammation
    • (no location specified)
    Nov 18, 2021

    Ocular Inflammation Trial (ISV-303, DuraSite Vehicle, Xibrom™)

    Completed
    Has Results
    • Ocular Inflammation
    • (no location specified)
    Nov 18, 2021

    Ocular Inflammation Trial (ISV-303, DuraSite Vehicle)

    Completed
    Has Results
    • Ocular Inflammation
    • (no location specified)
    Nov 18, 2021

    Cataract, Pain, Ocular Inflammation Trial in United States (Loteprednol Etabonate Ophthalmic Gel dosed TID, Loteprednol

    Completed
    Has Results
    • Cataract
    • +2 more
    • Loteprednol Etabonate Ophthalmic Gel dosed TID
    • +2 more
    • Phoenix, Arizona
    • +5 more
    Jan 6, 2021

    Ocular Inflammation Trial in United States (KPI-121 1%, Prednisolone acetate)

    Terminated
    Has Results
    • Ocular Inflammation
    • KPI-121 1%
    • Prednisolone acetate
    • Palo Alto, California
    • +3 more
    Sep 21, 2020

    Pterygium, Ocular Pain, Ocular Inflammation Trial in Guadalajara, Ciudad de México (PRO-155, Placebo)

    Completed
    Has Results
    • Pterygium
    • +3 more
    • Guadalajara, Jalisco, Mexico
    • +2 more
    Oct 30, 2019

    Dry Eye, Ocular Inflammation Trial in Birmingham (Eye wash)

    Completed
    • Dry Eye
    • Ocular Inflammation
    • Eye wash
    • Birmingham, Alabama
      University of Alabama at Birmingham
    May 15, 2019

    Ocular Discomfort, Ocular Inflammation, Dry Eye Trial (Lifitegrast)

    Withdrawn
    • Ocular Discomfort
    • +4 more
    • (no location specified)
    May 15, 2019

    Ocular Inflammation Trial in Trieste (Placebo, Dicloftil, Nevanac)

    Completed
    • Ocular Inflammation
    • Placebo
    • +4 more
    • Trieste, TS, Italy
      Eye Clinic, Departement of Medical Surgical Sciences and Health,
    Jul 21, 2018

    Corneal Endothelial Cell Loss, Ocular Pain, Ocular Inflammation Trial in United States (Placebo, 0.5% Omaveloxolone Ophthalmic

    Completed
    • Corneal Endothelial Cell Loss
    • +3 more
    • Placebo
    • +2 more
    • Laguna Hills, California
    • +14 more
    Jan 27, 2016

    Ocular Inflammation Trial in Overland Park (0.5% Loteprednol Etabonate Ophthalmic Ointment, Vehicle of Loteprednol Etabonate

    Completed
    Has Results
    • Ocular Inflammation
    • 0.5% Loteprednol Etabonate Ophthalmic Ointment
    • Vehicle of Loteprednol Etabonate Ophthalmic Ointment
    • Overland Park, Kansas
      John Hunkeler, MD
    Mar 4, 2015

    Ocular Inflammation Trial in High Point (Loteprednol Etabonate, Vehicle of Ophthalmic Loteprednol Etabonate)

    Completed
    Has Results
    • Ocular Inflammation
    • Loteprednol Etabonate
    • Vehicle of Ophthalmic Loteprednol Etabonate
    • High Point, North Carolina
      Cornerstone Eye Wear
    Mar 4, 2015

    Ocular Inflammation, Infection Associated Blepharitis, Keratitis Trial in São Paulo (azithromycin 1.5%/Loteprednol 0,5% + ,

    Withdrawn
    • Ocular Inflammation
    • +3 more
    • azithromycin 1.5%/Loteprednol 0,5% + placebo
    • azithromycin 1.5% + Loteprednol 0,5% (separately)
    • São Paulo, Brazil
      Department of Ophthalmology of Hospital São Paulo
    Dec 10, 2014

    Ocular Inflammation Trial in Eugene (IBI-10090)

    Terminated
    Has Results
    • Ocular Inflammation
    • Eugene, Oregon
      Drs. Fine, Hoffman, and Packer
    Sep 16, 2013

    Ocular Inflammation Trial in Sligo (triamcinolone acetonide, Maxitriol)

    Completed
    • Ocular Inflammation
    • Sligo, Ireland
      Sligo General Hospital
    Nov 12, 2008